3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Motor Activity
3
Sleep Wake Disorders
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Carcinoma
1
Fatigue
1
Endometrial Neoplasms
1
Depressive Disorder
1
Depression
1
Castration-Resistant Prostate Cancer (CRPC)
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Carcinoma In Situ
1
Anxiety Disorders
1
Interventions
relugolix
2
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Leuprolide
2
Goserelin
2
Biopsy
2
radium Ra 223 dichloride
1
luprolide acetate gel depot
1
histrelin
1
gallium 68 PSMA-11
1
enzalutamide
1
darolutamide
1
bicalutamide
1
Triptorelin Pamoate
1
Surgical Procedures, Operative
1
Salicylic Acid
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Flutamide
1
Buserelin
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Adenocarcinoma
×
Counseling
×
90 days
×
Clear all
No trials found.